Rani Therapeutics Hldgs segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Rani Therapeutics Hldgs utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
RANI | Rani Therapeutics Hldgs | -$0.24 | -$0.10 | — | — | $0.00 | — | — | — | 11/13/2025 | |
RANI | Rani Therapeutics Hldgs | -$0.26 | -$0.19 | -$0.18 | 5.26% | $0.00 | — | $0.00 | — | 08/07/2025 | |
RANI | Rani Therapeutics Hldgs | -$0.29 | -$0.24 | -$0.22 | 8.33% | $0.00 | — | $172.00K | — | 05/13/2025 | |
RANI | Rani Therapeutics Hldgs | -$0.27 | -$0.23 | -$0.27 | -17.39% | $0.00 | — | $1.03M | — | 03/31/2025 | |
RANI | Rani Therapeutics Hldgs | -$0.36 | -$0.27 | -$0.24 | 11.11% | $0.00 | — | $0.00 | — | 11/14/2024 | |
RANI | Rani Therapeutics Hldgs | -$0.37 | -$0.32 | -$0.26 | 18.75% | $0.00 | — | $0.00 | — | 08/06/2024 | |
RANI | Rani Therapeutics Hldgs | -$0.33 | -$0.31 | -$0.29 | 6.45% | $0.00 | — | $0.00 | — | 05/06/2024 | |
RANI | Rani Therapeutics Hldgs | -$0.35 | -$0.31 | -$0.27 | 12.90% | $0.00 | — | $0.00 | — | 03/20/2024 | |
RANI | Rani Therapeutics Hldgs | -$0.33 | -$0.37 | -$0.36 | 2.70% | $0.00 | — | $0.00 | — | 11/08/2023 | |
RANI | Rani Therapeutics Hldgs | -$0.31 | -$0.40 | -$0.37 | 7.50% | $0.00 | — | $0.00 | — | 08/11/2023 | |
RANI | Rani Therapeutics Hldgs | -$0.29 | -$0.41 | -$0.33 | 19.51% | $0.00 | — | $0.00 | — | 05/10/2023 | |
RANI | Rani Therapeutics Hldgs | -$0.27 | -$0.35 | -$0.35 | 0.00% | $0.00 | $110.00K | $0.00 | -100.00% | 03/22/2023 | |
RANI | Rani Therapeutics Hldgs | -$0.16 | -$0.47 | -$0.33 | 29.79% | $0.00 | — | $0.00 | — | 11/10/2022 | |
RANI | Rani Therapeutics Hldgs | -$0.12 | — | -$0.31 | — | $1.96M | — | $0.00 | — | 08/10/2022 | |
RANI | Rani Therapeutics Hldgs | $0.00 | — | -$0.29 | — | $756.00K | — | $0.00 | — | 05/11/2022 | |
RANI | Rani Therapeutics Hldgs | -$0.43 | -$0.49 | -$0.27 | 44.90% | $210.00K | $160.00K | $0.00 | -100.00% | 03/29/2022 | |
RANI | Rani Therapeutics Hldgs | — | -$0.18 | -$0.12 | 33.33% | $108.00K | $290.00K | $0.00 | -100.00% | 11/15/2021 | |
RANI | Rani Therapeutics Hldgs | -$0.06 | -$0.18 | -$0.12 | 33.33% | $60.00K | $490.00K | $1.96M | 300.20% | 09/13/2021 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-07 | $-0.18 | $-0.19 | 5.26 % |
Q1 | 2025-05-13 | $-0.22 | $-0.24 | 8.33 % |
Q4 | 2025-03-31 | $-0.27 | $-0.23 | -17.4 % |
Q3 | 2024-11-14 | $-0.24 | $-0.27 | 11.1 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q4 | 2023-03-22 | $0 | $110.00K | -100.0 % |
Q4 | 2022-03-29 | $0 | $160.00K | -100.0 % |
Q3 | 2021-11-15 | $0 | $290.00K | -100.0 % |
Q2 | 2021-09-13 | $1.96M | $490.00K | 300.2 % |
Si prevede che Rani Therapeutics Hldgs (RANI) fornisca risultati il novembre 13, 2025. Gli ultimi risultati sono stati pubblicati il agosto 7, 2025 per il Q2.
L'EPS effettivo era $-0.18, che superato la stima di $-0.19.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.